These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9873469)

  • 1. A novel series of 6-methoxy-1H-benzotriazole-5-carboxamide derivatives with dual antiemetic and gastroprokinetic activities.
    Hirokawa Y; Yamazaki H; Yoshida N; Kato S
    Bioorg Med Chem Lett; 1998 Aug; 8(15):1973-8. PubMed ID: 9873469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological profile of AS-9705, a novel benzotriazolecarboxamide derivative, as a gastroprokinetic agent with potent anti-emetic activity.
    Yoshikawa T; Mine Y; Morikage K; Yoshida N
    Arzneimittelforschung; 2003; 53(2):98-106. PubMed ID: 12642965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrogen-containing heteroalicycles with serotonin receptor binding affinity: development of gastroprokinetic and antiemetic agents.
    Kato S; Fujiwara I; Yoshida N
    Med Res Rev; 1999 Jan; 19(1):25-73. PubMed ID: 9918193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DAT-582, a novel serotonin3 receptor antagonist, is a potent and long-lasting antiemetic agent in the ferret and dog.
    Yoshida N; Omoya H; Ito T
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1159-65. PubMed ID: 1532032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new series of 6-chloro-2,3-dihydro-4(1H)-quinazolinone derivatives as antiemetic and gastrointestinal motility enhancing agents.
    Baldazzi C; Barbanti M; Basaglia R; Benelli A; Bertolini A; Piani S
    Arzneimittelforschung; 1996 Sep; 46(9):911-8. PubMed ID: 8876941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VB20B7, a novel 5-HT-ergic agent with gastrokinetic activity. II. Evaluation of the gastroprokinetic activity in rats and dogs.
    García-Garayoa E; Monge A; Roca J; Del Río J; Lasheras B
    J Pharm Pharmacol; 1997 Jan; 49(1):66-73. PubMed ID: 9120773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
    Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
    Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastroprokinetic activity of nizatidine, a new H2-receptor antagonist, and its possible mechanism of action in dogs and rats.
    Ueki S; Seiki M; Yoneta T; Aita H; Chaki K; Hori Y; Morita H; Tagashira E; Itoh Z
    J Pharmacol Exp Ther; 1993 Jan; 264(1):152-7. PubMed ID: 8093722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
    Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
    Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central antiemetic effects of AS-8112, a dopamine D2, D3, and 5-HT(3) receptor antagonist, in ferrets.
    Yoshikawa T; Yoshida N; Oka M
    Eur J Pharmacol; 2001 Nov; 431(3):361-4. PubMed ID: 11730730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piperazinylalkyl heterocycles as potential antipsychotic agents.
    Scott MK; Baxter EW; Bennett DJ; Boyd RE; Blum PS; Codd EE; Kukla MJ; Malloy E; Maryanoff BE; Maryanoff CA
    J Med Chem; 1995 Oct; 38(21):4198-210. PubMed ID: 7473547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxybenzamides with six- and seven-membered heteroalicycles as potential gastroprokinetic agents.
    Morie T; Kato S; Harada H; Yoshida N; Fujiwara I; Matsumoto J
    Chem Pharm Bull (Tokyo); 1995 Jul; 43(7):1137-47. PubMed ID: 7586057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDR-5169, a new gastrointestinal prokinetic agent, enhances gastric contractile and emptying activities in dogs and rats.
    Tazawa S; Masuda N; Koizumi T; Kitazawa M; Nakane T; Miyata H
    Eur J Pharmacol; 2002 Jan; 434(3):169-76. PubMed ID: 11779580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist.
    Yoshikawa T; Yoshida N; Oka M
    Br J Pharmacol; 2001 May; 133(2):253-60. PubMed ID: 11350861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber.
    Lee TH; Choi JJ; Kim DH; Choi S; Lee KR; Son M; Jin M
    Phytomedicine; 2008 Oct; 15(10):836-43. PubMed ID: 18490147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacology of 3,4-dihydro-3-oxo-1,4-benzoxazine-8-carboxamide derivatives, a new class of potent serotonin-3 (5-HT3) receptor antagonists.
    Kawakita T; Kuroita T; Yasumoto M; Sano M; Inaba K; Fukuda T; Tahara T
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):624-30. PubMed ID: 1611677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antiemetic drugs on decrease in gastric emptying in experimental model of motion sickness in rats.
    Gupta YK; Chaudhary G
    Acta Pharmacol Sin; 2003 Apr; 24(4):296-300. PubMed ID: 12676066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological effects of the new gastroprokinetic agent mosapride citrate and its metabolites in experimental animals.
    Yoshida N; Omoya H; Kato S; Ito T
    Arzneimittelforschung; 1993 Oct; 43(10):1078-83. PubMed ID: 8267674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.